{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:NFkappaB",
      "entity_text" : "NF-kappaB",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03463",
      "entity_text" : "Avoca ASU",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Avoca ASU, a combination of ASU and glucosamine sulfate, has been shown to suppress TNF-alpha, IL-1beta, COX2, iNOS, PGE2, NF-kappaB activation and nitrite production in articular chondrocytes and monocytes / macrophages, reducing pain and inflammation in OA patients.",
  "reading_complete" : "2020-08-04T23:17:32Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T23:15:30Z",
  "trigger" : "suppress",
  "evidence" : [ "Avoca ASU, a combination of ASU and glucosamine sulfate, has been shown to suppress TNF-alpha, IL-1beta, COX2, iNOS, PGE2, NF-kappaB" ],
  "pmc_id" : "4303902",
  "score" : 0
}